A Study of PD5K3 in Healthy Adult Volunteers

NCT06527781 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoblastic Leukemia, Acute
Lymphoblastic Lymphoma

Interventions

DRUG: PD5K3
DRUG: Placebo
DRUG: Pegaspargase

Sponsor

Chongqing Peg-Bio Biopharm Co., Ltd.